On May 5th, we opened a new lab for isolated perfused hearts. We are now able to implant our mitral valve repair devices in isolated animal and human hearts, showing the function of our implants. Direct endoscopic vision allows to monitor the deployment process and will guide interventionists for the training of clinical applications.The new facility extends the analysis of our AVVie repair systems. In addition, the AVVie integrated test facility can help enhance usability and mitigate use errors through repetitive usage of handling devices during the implantation process.
AVVie was awarded second place in the MedTech Virtual Tech Pitch competition, that was held on August 17. The competition was organised by state government office in Minnesota in partnership with Medical Alley Association, Launch Minnesota and SelectUSA.
Department of Employment and Economic Development (DEED) announced winners for foreign-owned Medical Technology (MedTech) companies 2 days later.
Out of the 32 MedTech companies from 13 different countries 5 finalists were selected and the 3 winners will have the opportunity to connect directly with a group of Minnesota based startup support programs.